Cornerstone Investment Partners’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,054
Closed -$179K 212
2025
Q2
$179K Buy
18,054
+8
+0% +$78 0.01% 173
2025
Q1
$169K Buy
+18,046
New +$190K 0.01% 147
2022
Q1
Sell
-8,300
Closed -$229K 233
2021
Q4
$229K Buy
+8,300
New +$229K 0.01% 202
2020
Q2
Sell
-12,960
Closed -$135K 170
2020
Q1
$135K Buy
+12,960
New +$163K 0.01% 132

Other funds holding ANGO

Cornerstone Investment Partners's ANGO Position: Q3 2025 in Review

Cornerstone Investment Partners sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 18,054 shares — an estimated $179K sold.

Cornerstone Investment Partners first reported a position in ANGO in Q1 2020 and held it in 4 quarters. The position peaked at $229K in Q4 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Cornerstone Investment Partners reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Cornerstone Investment Partners sold 18,054 AngioDynamics shares in Q3 2025, an estimated $179K.
  • Cornerstone Investment Partners first reported a position in AngioDynamics in Q1 2020 and held it in 4 quarters.
  • Cornerstone Investment Partners's AngioDynamics position peaked at $229K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Cornerstone Investment Partners's 13F filing for Q3 2025, filed 6 Nov 2025.